Randomized study of preoperative chemotherapy versus primary surgery for stage IB cervical cancer

The Journal of Obstetrics and Gynaecology Research
Hong-Bing CaiHou-Han Yin

Abstract

To determine the most effective treatment and long-term outcome of patients with stage IB carcinoma of the cervix. From January 1999 to December 2001, 106 women with cervical cancer stage IB received neoadjuvant chemotherapy (n = 52) or primary surgery (n = 54). These were randomly assigned. Clinical effects and pathological changes were simultaneously recorded. The overall clinical response rate was 84.6% and included a complete response (CR) in four patients (7.7%), partial response (PR) in 40 patients (76.9%), and stable disease (SD) in the remaining eight patients (15.4%). Surgery revealed positive nodes in 9.6% neoadjuvant chemotherapy group patients and in 29.6% primary surgery group patients (P = 0.014). Similar results occurred with vascular space involvement: 27.8% in the primary surgery group compared to 9.6% in the neoadjuvant chemotherapy group (P = 0.024). However, parametrial infiltration was found in 7.4% of the patients in the primary surgery group, while only 3.8% showed it in the neoadjuvant chemotherapy group (P = 0.679). The overall 5-year survival rate was significantly higher for all patients who received neoadjuvant chemotherapy (84.6%) than for the control group (75.9%) (P = 0.0112). The median survival ...Continue Reading

References

Jan 11, 1992·International Journal of Radiation Oncology, Biology, Physics·W W ThomsM J Oswald
Jun 1, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·L SouhamiT R Silveira
Jun 1, 1987·British Journal of Obstetrics and Gynaecology·F KirstenM Friedlander
Jan 1, 1988·Acta Oncologica·H R WithersB Maciejewski
Jul 1, 1986·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F Tannock, G Browman
Nov 1, 1980·American Journal of Obstetrics and Gynecology·C K ChungR Mortel
Jun 19, 1993·International Journal of Cancer. Journal International Du Cancer·D M ParkinJ Ferlay
Apr 1, 1996·American Journal of Clinical Oncology·B LeoneM Rabinovich
Sep 1, 1992·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M.H.N. TattersallM. Coppleson

❮ Previous
Next ❯

Citations

Feb 17, 2010·Archives of Gynecology and Obstetrics·Na WangTian-Gen Ni
Jun 18, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Silvia Rodríguez VillalbaJosé Manuel Cervera Grau
Feb 27, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·J PetsuksiriP Pattaranutaporn
Sep 25, 2015·Expert Review of Anticancer Therapy·Mariateresa LapresaNicoletta Colombo
Jan 26, 2016·The Journal of Obstetrics and Gynaecology Research·Yun-Hua PengLi Gao
Jul 24, 2012·Gynecologic Oncology·Roberto AngioliPierluigi Benedetti-Panici
Jun 26, 2009·Medical Hypotheses·Kidong KimSoon-Beom Kang
Jun 24, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·J F TierneyP Symonds
Oct 8, 2008·Annals of the New York Academy of Sciences·Nadja Dornhöfer, Michael Höckel
Oct 23, 2012·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·H S KimJ W Kim
Jan 19, 2013·Gynecologic Oncology·Roberto AngioliAlessia Aloisi
Jul 19, 2013·Gynecologic Oncology·Clare J ReadeAllan Covens
Apr 25, 2014·Journal of Gynecologic Oncology·Kanyarat KatanyooBusaba Supawattanabodee
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Larysa RydzewskaPaul R Symonds
Jul 29, 2011·Obstetrical & Gynecological Survey·Emily M Ko, Linda Van Le
Jan 18, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Bunja RungruangPaniti Sukumvanich
Jan 31, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Gabriele SiestoDomenico Vitobello
Jan 26, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hao WenShumo Cai
Aug 5, 2010·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Henry Charles KitchenerUNKNOWN Cervical Cancer Consensus Group
Oct 27, 2018·Journal of Magnetic Resonance Imaging : JMRI·Zhicong LiHan Wang
Mar 11, 2010·Expert Review of Anticancer Therapy·Manuela UndurragaPatrick Petignat
Feb 14, 2020·Current Oncology Reports·Shinya MatsuzakiKoji Matsuo
May 10, 2017·Medical Oncology·Daniela LuveroRoberto Angioli
Sep 2, 2020·The Journal of International Medical Research·Shu-Li YangYu-Mei Wu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.